痛风与12种心血管疾病的发病率:一项纳入152663例痛风患者和709981名匹配对照的病例对照研究
这项匹配病例对照研究利用英国临床实践研究数据链,纳入2000年1月1日至2017年12月31日首次诊断痛风且诊断时年龄≤80岁、诊断后12个月内无心血管疾病的个体,按年龄、性别、社会经济地位、地理区域和日历时间以最多1:5匹配对照。中位随访6.5年,痛风患者心血管疾病风险高于对照(HR 1.58 [95%CI 1.52-1.63]),女性(HR 1.88)和年轻个体(<45岁HR 2.22)超额风险更高,调整已知心血管危险因素后风险仍升高(校正HR 1.31 [1.27-1.36])。
要点
- 痛风患者12种心血管疾病风险均升高,总体HR 1.58(95%CI 1.52-1.63)。
- 女性超额风险高于男性(女性HR 1.88 vs 男性HR 1.49),<45岁人群HR最高为2.22。
- 调整已知心血管危险因素后风险仍升高(校正HR 1.31 [1.27-1.36])。
核心结论
- 痛风患者发生广泛心血管疾病的风险升高,范围超出动脉粥样硬化性疾病,还包括心力衰竭、心律失常、瓣膜病和血栓栓塞性疾病。
- 超额风险在女性和年轻个体中最高。
- 这些发现提示减少痛风患者心血管风险的策略需要演进并在临床实践中实施。
研究设计与样本
- 匹配病例对照研究,使用英国临床实践研究数据链关联的初级和次级电子健康记录。
- 纳入2000年1月1日至2017年12月31日首次诊断痛风、诊断时年龄80岁或以下、诊断后12个月内无心血管疾病的个体。
- 对照队列为每例痛风患者最多5名对照,按年龄、性别、社会经济地位、地理区域和日历时间匹配,从研究期前及期间任一时刻无痛风者中随机选取。
- 队列随访至2019年6月30日。
- 使用Cox比例风险模型分析痛风与非痛风者的差异,并按性别、年龄、社会经济地位和研究纳入年份进行亚组分析。
主要发现
- 共识别152663例痛风患者(平均年龄56.2岁[SD 13.3];120324例[78.8%]男性,32339例[21.2%]女性)和709981名匹配对照(平均年龄56.5岁[13.2];561002例[79.0%]男性,148979例[21.0%]女性)。
- 中位随访6.5年(IQR 3.1-10.5)期间,痛风患者中31479例(20.6%)发生心血管疾病,非痛风者中106520例(15.0%)发生心血管疾病。
- 痛风患者心血管疾病风险高于匹配对照(HR 1.58 [95%CI 1.52-1.63])。
- 痛风相关心血管疾病超额风险女性大于男性(女性HR 1.88 [1.75-2.02];男性HR 1.49 [1.43-1.56]),且在所研究的所有年龄组中年轻个体最高(<45岁人群HR 2.22 [1.92-2.57])。
- 所研究的全部12种心血管疾病均观察到超额风险。
关键数值与推荐
- 痛风患者与匹配对照相比心血管疾病总体HR 1.58(95%CI 1.52-1.63)。
- 女性痛风患者HR 1.88(95%CI 1.75-2.02),男性痛风患者HR 1.49(95%CI 1.43-1.56)。
- <45岁痛风患者HR 2.22(95%CI 1.92-2.57)。
- 校正已知心血管危险因素后HR 1.31(95%CI 1.27-1.36)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gout, a common crystal arthropathy, is associated with increased risk of cardiovascular disease. We aimed to identify how this risk varies by individual cardiovascular disease across a broad spectrum of conditions. METHODS: In this matched case-control study, we used linked primary and secondary electronic health records from the UK Clinical Practice Research Datalink to assemble a cohort of individuals with a first-time diagnosis of gout between Jan 1, 2000 and Dec 31, 2017, who were aged 80 years or younger at diagnosis, and free of cardiovascular diseases up to 12 months after diagnosis. The control cohort comprised up to five control individuals per patient with gout, matched on age, sex, socioeconomic status, geographical region, and calendar time, randomly selected among individuals free of gout at any time before and during the study period. The cohorts were followed up until June 30, 2019. We investigated the incidence of 12 cardiovascular diseases and used Cox proportional hazards models to examine differences in people with and without gout, overall and by subgroups of sex, age, socioeconomic status, and year of study inclusion. We further adjusted models for known cardiovascular risk factors (blood pressure, BMI, smoking status, cholesterol, type 2 diabetes, chronic kidney disease, and history of hypertension). FINDINGS: We identified 152 663 individuals with gout (mean age 56·2 years [SD 13·3]; 120 324 [78·8%] men and 32 339 [21·2%] women) and 709 981 matched controls (mean age 56·5 years [13·2]; 561 002 [79·0%] men and 148 979 [21·0%] women). Of these individuals, 31 479 (20·6%) with gout and 106 520 (15·0%) without gout developed cardiovascular disease during a median follow-up of 6·5 years (IQR 3·1-10·5). Patients with gout had higher risk of cardiovascular diseases than matched controls (hazard ratio [HR] 1·58 [95% CI 1·52-1·63]). Excess risk of cardiovascular disease in gout was greater in women than men (women: HR 1·88 [1·75-2·02]; men: HR 1·49 [1·43-1·56]), and, among all age groups, was highest in younger individuals (HR in people aged <45 years: 2·22 [1·92-2·57]). Excess risk was observed across all 12 cardiovascular diseases investigated. Patients with gout had higher BMI than matched controls (mean difference 2·90 kg/m2 [95% CI 2·87-2·93]) and higher prevalence of chronic kidney disease, dyslipidaemia, history of hypertension, obesity, and type 2 diabetes. Adjusting for known cardiovascular risk factors attenuated but did not eliminate the excess risk of cardiovascular disease related to gout (adjusted HR 1·31 [1·27-1·36]). INTERPRETATION: Patients with gout had an excess risk of developing a broad range of cardiovascular diseases that extend beyond atherosclerotic diseases and include heart failure, arrhythmias, valve disease, and thromboembolic diseases. Excess risk was highest in women and younger individuals. These findings suggest that strategies to reduce cardiovascular risk in patients with gout need to evolve and be implemented in clinical practice. FUNDING: Research Foundation Flanders.
引用
- Ferguson LD, Molenberghs G, Verbeke G, et al. Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatol. 2024. PMID: 38383089. doi:10.1016/S2665-9913(23)00338-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。